Showing results (11-20 of 52) with videos related to
Sort By:
Pageof 6
Arzneimittel-Forschung|August 5, 2000
Synthesis of methylamino-2-phenyl-2-butyl-3,4,5-trimethoxybenzoate, the main bioactive metabolite of trimebutine maleateA Martin, B Figadère, S Saivin, et al.Pathologie-Biologie|May 1, 1992
[Resistance to antibiotic treatment produced in a model of experimental Pseudomonas aeruginosa peritonitis]S Froidefond, S Saivin, J Lemozy, et al.Arzneimittel-Forschung|August 26, 1998
Blood and cerebral concentrations of the new potential analgesic UP 26-91 measured in vivo by microdialysis after toxic dosesR Bouër, S Saivin, M F Malmary, et al.Journal of Pharmacological and Toxicological Methods|February 1, 1995
Microdialysis probes calibration: gradient and tissue dependent changes in no net flux and reverse dialysis methodsA Le Quellec, S Dupin, P Genissel, et al.Thrombosis and Haemostasis|May 4, 1992
Pharmacodynamic properties of long lasting butyryl heparin derivatives in the rabbitS Saivin, C Caranobe, M Petitou, et al.Advances in Space Biology and Medicine|January 1, 1997
Pharmacology in space: pharmacokineticsS Saivin, A Pavy-Le Traon, C Soulez-LaRivière, et al.Fundamental & Clinical Pharmacology|January 1, 1994
Comparison of the "zero crossing" method in derivative spectroscopy and ultrafiltration for the determination of free and bound fractions of mitoxantroneM B Maia, A E Tufenkji, M A Rochas, et al.International Journal of Clinical Pharmacology and Therapeutics|April 10, 2007
Intermittent administration of ceftazidime to burns patients: influence of glomerular filtrationJ M Conil, B Georges, O Fourcade, et al.Thrombosis and Haemostasis|June 30, 1989
Unfractionated heparin and CY 216: pharmacokinetics and bioavailabilities of the antifactor Xa and IIa effects after intravenous and subcutaneous injection in the rabbitL Briant, C Caranobe, S Saivin, et al.Advances in Space Biology and Medicine|January 1, 1997
Pharmacology in space: pharmacotherapyA Pavy-Le Traon, S Saivin, C Soulez-LaRivière, et al.Pageof 6